Skip to main content
Premium Trial:

Request an Annual Quote

NYS DOH Approves Cancer Exome Sequencing Tests from Columbia U, Weill Cornell Medicine

NEW YORK (GenomeWeb) – The New York State Department of Health recently approved two separate cancer whole-exome sequencing tests from Columbia University and from Weill Cornell Medicine and New York-Presbyterian.

Both tests aim to help doctors make therapy decisions for cancer patients.

Columbia University's cancer whole exome and transcriptome test, which is offered by the Laboratory for Personalized Genomic Medicine, was launched about a year ago, initially for pediatric cancer patients. The test sequences DNA and mRNA from frozen tumor samples and normal controls and has a turnaround time of 60 days. It detects cancer-specific missense, indel, and copy number changes; chimeric RNA and RNA with altered expression levels; and inherited mutations that predispose to cancer. According to Peter Nagy, one of the laboratory's directors, it was recently approved by New York state.

Weill Cornell Medicine and New York-Presbyterian/Weill Cornell Medical Center's cancer exome sequencing test, called EXaCT-1, was developed by the institution's precision medicine team and is currently available to patients with advanced cancers through the Caryl and Israel Englander Institute for Precision Medicine, a research institute. 

This summer, the team, led by Mark Rubin, director of the Englander Institute and professor of oncology and pathology at Weill Cornell Medicine, published a feasibility study of the test in JAMA Oncology. The study examined 97 patients with metastatic and treatment-resistant cancers and found that whole-exome sequencing provided informative results in 94 percent of cases. The test involves the analysis of a tumor sample and normal control.

Following the recent approval of EXaCT-1 by New York state, the test will be implemented for large-scale clinical use in oncology patients treated at New York-Presbyterian/Weill Cornell, according to the institution.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.